Nuvation Bio, Inc. Class A NUVB
NYSE · United States · Health Technology
$5.57-0.03 (-0.62%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.18 | -0.14 | -27.1% | $31.69M | +17.2% | +3.6%$6.37→$6.60 |
| Q1 2026 | 2026-05-04 | 0.04 | 0.05 | -20.0% | — | — | +7.6%$4.49→$4.83 |
| Q4 2025 | 2026-03-02 | -0.09 | -0.04 | -125.0% | — | — | -26.2%$5.91→$4.36 |
| Q3 2025 | 2025-11-03 | -0.16 | -0.17 | +5.9% | — | — | -7.5%$5.22→$4.83 |
| Q2 2025 | 2025-08-07 | -0.14 | -0.14 | 0.0% | — | — | — |
| Q1 2025 | 2025-05-07 | -0.13 | -0.12 | -8.3% | — | — | — |
| Q4 2024 | 2025-03-06 | -0.12 | -0.12 | 0.0% | — | — | — |
| Q3 2024 | 2024-11-06 | -0.12 | -0.10 | -20.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.